BRIACELL THERAPEUTICS CORP. Tax Effect From Change In Tax Rate
BRIACELL THERAPEUTICS CORP. (BCTX) reported Tax Effect From Change In Tax Rate of $5.89 thousand for the 12-month period ending 2019-07-31, per its 40-F/A filed 2021-11-16.
Discontinued › Notes
ifrs-full:TaxEffectFromChangeInTaxRate · last filed 2021-11-16
| Period end | Tax Effect From Change In Tax Rate 12 month |
|---|---|
| 2019-07-31 | $5.89K 40-F/A · filed 2021-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |